Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: A case report

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 10, 2013, Pages 1311-1313

  Liu, Y J ^a   Du, P ^a   Rao, J ^a  

^a not available

Author keywords

Diagnosis; Intestinal infections; Procalcitonin; Sepsis

Indexed keywords

CIPROFLOXACIN; IMIPENEM; MEROPENEM; PROCALCITONIN;

AGED; ARTICLE; CASE REPORT; DIARRHEA; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; INTESTINE INFECTION; LABORATORY TEST; SENSITIVITY AND SPECIFICITY; SEPSIS; VOMITING;

EID: 84878579622     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LE MOULLEC JM, JULLIENNE A, CHENAIS J, LASMOLES F, GULIANA JM, MILHAUD G, MOUKHTAR MS. The complete sequence of human preprocalcitonin. FEBS Lett 1984; 167: 93-97.
2. BROAD PM, SYMES AJ, THAKKER RV, CRAIG RK. Structure and methylation of the human calcitonin/alpha-CGRP gene.Nucleic Acids Res 1989; 17: 6999-7011.
3. BELL K, WATTIE M, BYTH K, SILVESTRINI R, CLARK P, STACHOWSKI E, BENSON EM. Procalcitonin: a marker of bacteraemia in SIRS. Anaesth Intensive Care 2003; 31: 629-636.
4. ASSICOT M, GENDREL D, CARSIN H, RAYMOND J, GUILBAUD J, BOHUON C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518.
5. LICHTENSTERN C, BRENNER T, BARDENHEUER HJ, WEIGAND MA. Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis 2012; 25: 328-336.
6. HAGIWARA A, WADA T, SASAKI R, SATO T, KOBAYASHI K, KIMURA A. Efficacy of semiquantitatively measured serum procalcitonin as a guide to cessation of antibiotictherapy in septic patients. J Infect 2012; 65: 187-189.
7. DELLINGER RP, LEVY MM, CARLET JM, BION J, PARKER MM, JAESCHKE R, REINHART K, ANGUS DC, BRUN-BUISSON C, BEALE R, CALANDRA T, DHAINAUT JF, GERLACH H,HARVEY M, MARINI JJ, MARSHALL J, RANIERI M, RAMSAY G, SEVRANSKY J, THOMPSON BT, TOWNSEND S, VENDER JS, ZIMMERMAN JL, VINCENT JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
8. LEVY MM, DELLINGER RP, TOWNSEND SR, LINDE-ZWIRBLE WT, MARSHALL JC, BION J, SCHORR C, ARTIGAS A, RAMSAY G, BEALE R, PARKER MM, GERLACH H, REINHART K, SILVA E, HARVEY M, REGAN S, ANGUS DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36: 222-231.
9. SILVESTRE J, PÓVOA P, COELHO L, ALMEIDA E, MOREIRA P, FERNANDES A, MEALHA R, SABINO H. Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 2009; 35: 909-913.
10. AIKAWA N, FUJISHIMA S, ENDO S, SEKINE I, KOGAWA K, YAMAMOTO Y, KUSHIMOTO S, YUKIOKA H, KATO N, TOTSUKA K, KIKUCHI K, IKEDA T, IKEDA K, HARADA K, SATOMURA S. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005; 11: 152-159.
11. BALCI C, SUNGURTEKIN H, GÜRSES E, SUNGURTEKIN U, KAPTANOGLU B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7: 85-90.
12. VIALLON A, GUYOMARC'H S, MARJOLLET O, BERGER C, CARRICAJO A, ROBERT F, LAPORTE S, LAMBERT C, PAGE Y,ZÉNI F, BERTRAND JC. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med 2008; 15: 26-33.
13. CHAN YL, TSENG CP, TSAY PK, CHANG SS, CHIU TF, CHEN JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004; 8: 12-20.
14. KIBE S, ADAMS K, BARLOW G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011; 66: 33-40.
15. KIM HS, YANG HT, HUR J, CHUN W, JU YS, SHIN SH, KANG HJ, LEE KM. Procalcitonin Levels within 48 Hours After Burn Injury as a Prognostic Factor. Ann Clin Lab Sci 2012; 42: 57-64.